The DC MatureTissue programme is based on a network of researchers at UASTW and TUW, who either have been collaborating for a number of years or have recently started a collaboration. Importantly, strong common goals have been identified among all faculty members in the area of maturation of in vitro tissue models, which emerge from different interests and aspects. The doc.funds.connect is hence a perfect platform to provide a foundation for these joint interests on the basis of the DC MatureTissue, and is expected to bring the involved groups closer together solidify the collaborations and strengthen the consortium on the national or European level.
Dr. Peter Ertl is Professor of Lab-on-a-Chip Systems for Bioscience Technologies at the Faculty of Technical Chemistry. His research focuses on the development of advanced in vitro diagnostic microsystems, lab-on-a-chip technologies and organ-on-a-chip systems. Dr. Ertl is also founder and speaker of the Austrian Microfluidic Initiative, Editor-in-Chief of the open access journal Organs-on-a-Chip and Chief Technology officer (CTO) of SAICO Biosystems KG as well as Co-founder of Pregnerate GmbH.
Dr. Olivier Guillaume received his PhD in 2011 in the field of biomaterials for biomedical application. He spent a few years abroad in postdoc positions in the field of Tissue Engineering (Ireland, Switzerland and now Austria). He is now part of the 3D Printing and Biofabrication Group of TU Wien. In 2020, he received a Stand Alone grant from FWF to conduct research in bioprinting biofilm to tackle bacteria multi-resistance issue.
Dr. Holnthoner is a trained endothelial cell biologist, interested in the basic functions of these cells in vasculogenesis, angiogenesis and lymphangiogenesis. His group’s primary focus is the regeneration/engineering of microvascular structures. In addition, his research involves the integration of lymphatic vessels, since they are the ones, which transport the interstitial fluid in tissues back to the blood circulation, and without them human life would be inconceivable. Moreover, he strives to explore the emerging role of extracellular vesicles (EV) in intercellular communication. These efforts contribute to the development of therapies aimed for regeneration of diseased tissues. Moreover, he is ccredited Supervisor in the PhD program “Vascular Biology” at the Medical University of Vienna.
Dr. Carina Huber-Gries studied food- and biotechnology at the University of Natural Ressources and Life Sciences (BOKU) in Vienna. She worked within the research group NanoBiotechology at BOKU in the group “Molecular Biotechnolgoy” and completed several research stays at the Max Planck Intitue for Polymer Research in Mainz, Germany. Her most important research achievement at BOKU was the design and construction of a DNA-biochip based on S-Layer-Streptavidin fusion proteins. AT UASTW she is the head of the Department Life Science Engineering and her main research interests are bioreactor and microfluidic systems. In the latter one she was successful to establish a microfluidic facility at the UASTW, which is mainly used for R&D projects with industry as well as academic partners. Her strong expertise in molecular biotechnology give important impulses in the development of tissue models as well as bioreactor models at the UASTW.
Dr. Martina Marchetti-Deschmann is Full Professor for Mass Spectrometric Methods / Analytical Chemistry. Heading the Research Group of Mass Spectrometric Bio- and Polymer Analysis in the Research Division of Imaging and Instrumental Analytical Chemistry focusing on method /instrumentation development. Recently she focused on correlative and multimodal imaging allowing comprehensive knowledge collection across the scales, including MS imaging, a method enabling the mapping of thousands of molecules within biological systems.
Dr. Aleksandr Ovsianikov is Professor and the Head of the research group 3D Printing and Biofabrication. His research is dealing with the use of additive manufacturing technologies and bioprinting for tissue engineering and regeneration. Dr. Ovsianikov was awarded prestigious ERC Starting Grant in 2012 and an ERC Consolidator Grant in 2017 for projects aimed at these topics. He is also a co-founder and a head of research of a TU Wien spin-off UpNano.
Dr. Teuschl-Woller studied chemical engineering at the University of Technology, Vienna. He finished his diploma thesis in 2008 and his PhD thesis in 2012, both in the field of structural proteins including collagen and silk protein at the Ludwig Boltzmann Institute for Clinical and Experimental Traumatology/AUVA Research Center. In 2012 he joined the UAST and is currently heading the master study program “Tissue Engineering and Regenerative Medicine” and the research coordinator for “Tissue Engineering and Molecular Life Science Technologies”. In 2015 he was invited to join Prof. Kaplan’s lab at Tufts University in Boston for a 6-month research stay to pursue joint ideas on silk proteins for tissue engineering applications. Dr. Teuschl´s most important research results achieved to date are his work on silk fibroin as a biomaterial, where he invented a purification method for silk proteins and a novel modification strategy. proteins. Both techniques are used in the company Morphomed GmbH, which Dr. Teuschl co-funded. Further achievements of his scientific career are the design and establishment of variour bioreactor systems at the UASTW.
Dr. Philipp Thurner is Professor of Biomechanics at the Institute of Lightweight Design and Structural Biomechanics (ILSB). He is head of the Research Division Biomechanics and head of the ILSB. His research is focused on the micro-and nano-mechanics of biological tissue based on the idea that mechanical characterization of biological tissue biopsies will aid diagnosis and treatment of diseases in the future, and can so complement and inform correlative imaging approaches including classical clinical imaging techniques.
Dr. Anna Weihs did her master studies „Biomedical Engineering Sciences“ at the University of
Applied Sciences Technikum Wien, which was followed by her PhD studies at the Medical
University in Vienna. In 2011 she was invited for a research stay in the group of Prof. Junger at
the Harvard Mecial School/BIDMC in Boston. Dr. Weihs is a Senior Scientist/Lecturer at the
Department of Life Science Engineering at UASTW. Her research focuses on reveiling cellular
signaling and mechanotransduction mechanisms involved in extracorporeal shockwave
treatment and in tissue engineering approaches.
Dr. Helene Zirath did her master of Science in Biotechnology at the University of Lund in Sweden. She continued with her PhD thesis at TUW, where her scientific fosus was on the development of organ-on-a chip systems with integrated sensors for toxicity screening and the development of Point-of-Care Testing devices for automated in vitro diagnostics of biomarkers in blood plasma, serum and saliva. She is Post-Doc and project assistant in the group of Prof. Peter Ertl, where is involved in research but also the project management of various national and international projects (e.g. FFG TRACE, or H2020-WIEDSPREAD-2018-2020).